Design, Virtual Screening and Docking Study of Novel NS3 Inhibitors by Targeting Protein-protein Interacting Sites of Dengue Virus - A Novel Approach

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|11|995-1008

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.11, 2013-11, pp. : 995-1008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Scouting Novel Protein Kinase A (PKA) Inhibitors by Using a Consensus Docking-Based Virtual Screening Approach

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 327-336

Bentham Science Publishers

Access to resources Recommend Favorite

Toward the Identification of Novel Carbonic Anhydrase XIV Inhibitors using 3D-QSAR Pharmacophore Model, Virtual Screening and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 7, 2015-06 ,pp. : 553-581

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Novel Biphenyl-2-thioxothiazolidin-4-one Derivatives as Potential Protein Tyrosine Phosphatase (PTP)-1B Inhibitors Using Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 4, 2016-05 ,pp. : 295-300

Bentham Science Publishers

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite